Literature DB >> 28010898

The etiopathogenesis of diffuse low-grade gliomas.

Amélie Darlix1, Catherine Gozé2, Valérie Rigau3, Luc Bauchet4, Luc Taillandier5, Hugues Duffau6.   

Abstract

The origins of diffuse low-grade gliomas (DLGG) are unknown. Beyond some limited data on their temporal and cellular origins, the mechanisms and risk factors involved are poorly known. First, based on strong relationships between DLGG development and the eloquence of brain regions frequently invaded by these tumors, we propose a "functional theory" to explain the origin of DLGG. Second, the biological pathways involved in DLGG genesis may differ according to tumor location (anatomo-molecular correlations). The cellular and molecular mechanisms of such "molecular theory" will be reviewed. Third, the geographical distribution of diffuse WHO grade II-III gliomas within populations is heterogeneous, suggesting possible environmental risk factors. We will discuss this "environmental theory". Finally, we will summarize the current knowledge on genetic susceptibility in gliomas ("genetic predisposition theory"). These crucial issues illustrate the close relationships between the pathophysiology of gliomagenesis, the anatomo-functional organization of the brain, and personalized management of DLGG patients.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Anatomo-molecular correlations; Brain–tumor interactions; Diffuse low-grade gliomas; Eloquent areas; Environmental risk factors; Genetic susceptibility; Oligodendroglial progenitor cells; Ultrastructural mechanisms

Mesh:

Year:  2016        PMID: 28010898     DOI: 10.1016/j.critrevonc.2016.11.014

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  10 in total

1.  Development and validation of an MRI-based nomogram for the preoperative prediction of tumor mutational burden in lower-grade gliomas.

Authors:  En-Tao Liu; Shuqin Zhou; Yingwen Li; Siwei Zhang; Zelan Ma; Junbiao Guo; Lei Guo; Yue Zhang; Quanlai Guo; Li Xu
Journal:  Quant Imaging Med Surg       Date:  2022-03

Review 2.  Network Plasticity and Intraoperative Mapping for Personalized Multimodal Management of Diffuse Low-Grade Gliomas.

Authors:  Cristina Diana Ghinda; Hugues Duffau
Journal:  Front Surg       Date:  2017-01-31

3.  Angiotensin-converting enzyme insertion/deletion gene polymorphisms and the risk of glioma in an Algerian population.

Authors:  Ikram Hana Benenemissi; Karima Sifi; Lakhder Khalil Sahli; Ouarda Semmam; Noureddine Abadi; Dalila Satta
Journal:  Pan Afr Med J       Date:  2019-04-23

4.  An autophagic gene-based signature to predict the survival of patients with low-grade gliomas.

Authors:  Jian Chen; Yuntian Li; Xinghua Han; Yueyin Pan; Xiaojun Qian
Journal:  Cancer Med       Date:  2021-02-16       Impact factor: 4.452

5.  METTL21B is a prognostic biomarker and potential therapeutic target in low-grade gliomas.

Authors:  Xin Shu; Xinquan Li; Xiaochen Xiang; Qiang Wang; Qingming Wu
Journal:  Aging (Albany NY)       Date:  2021-08-26       Impact factor: 5.682

Review 6.  White Matter Tracts and Diffuse Lower-Grade Gliomas: The Pivotal Role of Myelin Plasticity in the Tumor Pathogenesis, Infiltration Patterns, Functional Consequences and Therapeutic Management.

Authors:  Hugues Duffau
Journal:  Front Oncol       Date:  2022-03-02       Impact factor: 6.244

7.  Preoperative imaging features: Are they useful tools for predicting IDH1 mutation status in gliomas Grades II-IV?

Authors:  Martin Andres Merenzon; Jose Ignacio Gómez Escalante; Diego Prost; Eduardo Seoane; Alejandro Mazzon; Érica Rojas Bilbao
Journal:  Surg Neurol Int       Date:  2022-08-05

8.  Prognostic Model and Nomogram Construction and Validation With an Autophagy-Related Gene Signature in Low-Grade Gliomas.

Authors:  Xinrui Li; Zhiyuan Huang; Lei Zhu; Fei Yu; Minghao Feng; Aiqin Gu; Jianxin Jiang; Guangxue Wang; Dongya Huang
Journal:  Front Genet       Date:  2022-07-18       Impact factor: 4.772

9.  Association between health insurance status and malignant glioma.

Authors:  Igor Fischer; Hendrik-Jan Mijderwijk; Ulf D Kahlert; Marion Rapp; Michael Sabel; Daniel Hänggi; Hans-Jakob Steiger; Marie-Therese Forster; Marcel A Kamp
Journal:  Neurooncol Pract       Date:  2020-06-06

10.  Brain Mapping as Helpful Tool in Brain Glioma Surgical Treatment-Toward the "Perfect Surgery"?

Authors:  Fabio Barone; Nicola Alberio; Domenico Gerardo Iacopino; Giuseppe Roberto Giammalva; Corrado D'Arrigo; Walter Tagnese; Francesca Graziano; Salvatore Cicero; Rosario Maugeri
Journal:  Brain Sci       Date:  2018-10-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.